Application Value of Metagenomics Next-Generation Sequencing (mNGS) in Detection of Mucormycosis after Chemotherapy in Childhood Acute Leukemia.

Li W, Zhu H, Wen L, Quan M, Wang L

Open source

DOI
10.1155/2022/7366432
Published
2022
Container
Evidence-based complementary and alternative medicine : eCAM
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/2022/7366432,
  title = {Application Value of Metagenomics Next-Generation Sequencing (mNGS) in Detection of Mucormycosis after Chemotherapy in Childhood Acute Leukemia.},
  author = {Li W and Zhu H and Wen L and Quan M and Wang L},
  year = {2022},
  journal = {Evidence-based complementary and alternative medicine : eCAM},
  doi = {10.1155/2022/7366432},
  url = {https://doi.org/10.1155/2022/7366432}
}

RIS

TY  - JOUR
TI  - Application Value of Metagenomics Next-Generation Sequencing (mNGS) in Detection of Mucormycosis after Chemotherapy in Childhood Acute Leukemia.
AU  - Li W
AU  - Zhu H
AU  - Wen L
AU  - Quan M
AU  - Wang L
PY  - 2022
JO  - Evidence-based complementary and alternative medicine : eCAM
DO  - 10.1155/2022/7366432
UR  - https://doi.org/10.1155/2022/7366432
ER  - 

APA

W, L., H, Z., L, W., M, Q., & L, W. (2022). Application Value of Metagenomics Next-Generation Sequencing (mNGS) in Detection of Mucormycosis after Chemotherapy in Childhood Acute Leukemia.. Evidence-based complementary and alternative medicine : eCAM. https://doi.org/10.1155/2022/7366432

Source records